Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

ADVERTISEMENT

Does Single Dose of COVID-19 Vaccine Provide Protection against Variants?

A recent study suggests that single dose of Pfizer/BioNTech mRNA vaccine BNT162b2 provide protection against the new variants among individuals with prior infection.  

The massive immunisation programme against the pandemic COVID-19 is currently underway. Simultaneously, there are reports of emergence of new variants of concern of SARS-CoV-2 virus. With the countries like UK having successfully given first dose to significant section of population, the question is often raised about effectiveness of single dose of COVID vaccine in providing adequate protection against the new variants of SARS-CoV-2 virus.  

A recent study has looked in this aspect for Pfizer’s mRNA vaccine. The researchers investigated if single dose vaccination provides cross protective immunity to variants.  

Upon analysis of T and B cell responses after first dose vaccination with the Pfizer/BioNTech mRNA vaccine BNT162b2 in healthcare workers, the researchers found that those with prior infections had enhanced T cell immunity, antibody secreting memory B cell response to spike and neutralizing antibodies effective against B.1.1.7 and B.1.351. On the other hand, in individuals without prior infection, the single dose of the vaccine showed reduced immune response against variants. B.1.1.7 and B.1.351 spike mutations.  

***

Source:  

Reynolds C., Pade C., et al 2021. Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose. Science. Published 30 Apr 2021: eabh1282. DOI: https://doi.org/10.1126/science.abh1282  

SCIEU Team
SCIEU Teamhttps://www.ScientificEuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Most Popular Articles

Revival of Pigs Brain after Death : An Inch Closer to Immortality

Scientists have revived pigs brain four hours after its...

PARS: A Better Tool to Predict Asthma Among Children

Computer-based tool has been created and tested for predicting...
- Advertisement -
93,368FansLike
47,367FollowersFollow
1,772FollowersFollow
30SubscribersSubscribe